Dermspectra Leadership

Karleen Seybold

Co-Founder & Chief Executive Officer

Karleen Seybold is the Co-Founder and Chief Executive Officer at DSI. DermSpectra Total Body Digital Skin Imaging System enables physicians to detect, track, and monitor critical skin changes (skin cancers, eczema, moles, psoriasis, and rashes) to ensure the best healthcare outcomes for patients. Bringing more than 20 years of engineering and executive management experience to DermSpectra, Karleen leads the strategic planning and technology development at DermSpectra, as well as directs the management and overall direction of the company.  In 2015, DermSpectra was named as a top 10 finalist out of 154 companies in the Arizona Innovation Challenge.  Karleen Seybold was awarded an Outstanding Female Entrepreneur award by Inside Tucson Business in March 2015.

The DermSpectra Total Body Digital Skin Imaging System is a proprietary solution that delivers patented high-resolution imaging, secure storage, and immediate viewing capabilities. With the most advanced level of imaging precision in the market, DermSpectra sets the industry standard (definition, timing, lighting, image quality, data formats, secure storage, and interfaces) in digital skin imaging for dermatologists, plastic surgeons, cancer centers, clinical trials, general practitioners, and telemedicine services.

DermSpectra’s imaging solution strives to improve early detection of melanomas and treatment outcomes for patients and physicians by providing standardized, high-definition digital skin images that enable comparison of skin lesions and body changes over time. DermSpectra fills a critical gap in the digital skin imaging (DSI) market. Despite more than 5.0 million new cases of skin cancer diagnosed each year in the U.S., there are few readily available tools for screening and early detection of skin cancer at the total body level, making the DermSpectra Total Body Digital Skin Imaging System an industry-leading technology solution.  DermSpectra was the 2015 recipient of Best Use of Technology and Best Manufacturing awards by Inside Tucson Business.

Before co-founding DermSpectra, Karleen was a Program Manager and Senior Systems Engineer at Raytheon Company for 17 years where she led new business development efforts through innovative technology applications and directed an international new business effort in missile defense.

She holds five patents for image sequencing, alignment, and a skin cancer detection display module and received six Technology Achievement awards from Raytheon. She earned her Bachelor of Science degree in mechanical engineering from Northern Arizona University and her MBA in Global Management from Thunderbird International School of Global Management. Her work has been published in national and international trade publications.

Karleen can be contacted by emailing kgseybold@dermspectra.com. Visit her LinkedIn profile here.


Linda A. Fanaras

Executive Vice President

Linda Fanaras (EVP) is the Executive Vice President at DSI. DermSpectra Total Body Digital Skin Imaging System enables physicians to detect, track, and monitor critical skin changes (skin cancers, eczema, moles, psoriasis, and rashes) to ensure the best healthcare outcomes for patients. Bringing more than 20 years of marketing, operations and executive management experience to DermSpectra, Linda leads and oversees the company’s marketing, sales and operational functions. Linda has extensive expertise in health care, medical device technologies and imaging marketing services. She is also the President and Founder of Millennium Integrated Marketing, a highly respected, award-winning strategic creative strategy, digital and public relations firm with offices in Manchester, New Hampshire and Boston.

Ms. Fanaras is a stakeholder and member of the Communications Team for the Health Information Exchange Planning and Implementation (HIEPI) project for the New Hampshire Department of Health and Human Services (NH DHHS). Her role is to assist with the development of a HIEPI Communications Plan. Linda currently holds positions with the Business and Industry Association’s Board of Directors and Executive and Governance Committees, and also holds a Board of Directors position on the American Association of Advertising Agencies’ New England Governor’s Council, which serves as a national collaboration team to develop best practices for advertising agencies.

Linda has focused in health marketing since its inception in 1996 – including hospitals, social service agencies, physician groups, and non-profit organizations – in achieving public education, awareness, outreach, funding, and public policy goals. A sampling of these clients include: Department of Health and Human Services, New Hampshire Healthy Kids, Speare Memorial Hospital, Visiting Nurse Association (VNA), March of Dimes, Endowment for Health, Women, Infants, and Children (WIC), Tufts Health Plan, Northeast Deaf and Hard of Hearing Services, and The Prescription Center. She has significant experience in medical device marketing, healthcare marketing and healthcare software technology.

She has a Bachelor’s of Science and a marketing concentration from Franklin Pierce University, an MBA, and is currently attending Northeastern University for a Graduate Certificate in Medical Device Regulations. She has been a regional and national speaker on topics ranging from healthcare marketing to lead generation.

Linda Fanaras, Executive Vice President can be contacted by emailing lfanaras@dermspectra.com. Visit her LinkedIn profile here.


Jason Bodnick

Vice President Sales

Mr. Bodnick has been a founder and officer in private & public companies serving the medical technology, retail technology, consumer packaged goods, and real estate markets for the past 20 years. Presently, Mr. Bodnick is a Chief Operating Officer at ARC Devices USA, Inc., multi-national medtech company that harnesses the power of innovative non-touch sensor and connected communication technologies to change the way patients and clinicians measure health. At ARC, Mr. Bodnick led the successful turnaround and consolidation of a distressed multi-national medtech start-up resulting in the launch of the Company’s first two devices within the first nine (9) months, establishment of national distribution in both clinical and retail channels, and the development of ARC’s Multi-Vital Signs Device and video based Motion Amplification vital signs measurement technologies.

Prior to ARC, Mr. Bodnick co-founded and operated X8 Brands from 2010 to 2014, a nutraceutical chewing gum manufacturer in Palm Beach Gardens, FL. While at X8, Mr. Bodnick successfully raised the seed capital and led the development and distribution of X8 Energy Gum and CevaSlim Weight Loss Gum via online and specialty retail outlets.

From 2002 to 2009, Mr. Bodnick co-founded Nexxus Group Properties, LLC, a real estate development firm in Southeastern Michigan. During his tenure at Nexxus, Mr. Bodnick was responsible for all facets of the company’s financing, syndication, site selection, development, and marketing of the company’s portfolio of residential and multifamily projects.

Prior to that Mr. Bodnick served as the Vice President of Client Strategic Services for Imagicast, Inc., a technology start-up with IPO aspirations developing the first end-to-end wirelessly networked interactive, shelf edge, collaborative marketing/merchandising solution for retailers and brands.  In that role, he secured a strategic relationship and investment with P&G, and spearheaded the development and national in-store deployment of the company’s interactive wireless shelf-edge marketing system.

Between 1997 to 1999, Mr. Bodnick served as the CEO of Valley Research Systems, a packaged goods manufacturer where he led the development and marketing of a custom line of products distributed in national retail clients such as Bed, Bath & Beyond, Linens N Things, and Kmart. Mr. Bodnick began his career at Salomon Brothers on the mortgage backed securities desk. Mr. Bodnick received a BA in Political Science from Rutgers University.


Richard Carmona

M.D., M.P.H., FACS | 17th U.S. Surgeon General DermSpectra Medical and Business Advisory Board Member

In 2006, Dr. Carmona successfully completed the statutory four-year term of the U.S. Surgeon General and was named to the position of vice chairman of Canyon Ranch, the country’s leading health and wellness company for over 30 years, and was named president of the Canyon Ranch Institute Board of Directors. Canyon Ranch Institute, a 501(c)3 non-profit public charity, catalyzes the possibility of optimal health for all people by translating the best practices of Canyon Ranch and its partners to help educate, inspire, and empower every person to prevent disease and choose a life of wellness.

Dr. Carmona enlisted in the U.S. Army in 1967. While serving, he earned his General Equivalency Diploma and went on to become a combat-decorated Special Forces Vietnam veteran. After leaving active duty, he attended Bronx Community College of the City University of New York through an open enrollment program for veterans. He received an Associate of Arts degree. He then attended the University of California, San Francisco, where he received a Bachelor of Science degree (1977) and medical degree (1979). At the University of California Medical School, Dr. Carmona was awarded the prestigious gold-
headed cane as the top graduate.

Trained in general and vascular surgery, Dr. Carmona also completed a National Institutes of Health-sponsored fellowship in trauma, burns, and critical care. Dr. Carmona was then recruited jointly by the Tucson (Arizona) Medical Center and the University of Arizona to start and direct Arizona’s first regional trauma care system. He went on to become the chairman of the State of Arizona Southern Regional Emergency Medical System, a professor of surgery, public health and family and community medicine at the University of Arizona, and the Pima County Sheriff’s Department surgeon and deputy sheriff. He is also a Fellow of the American College of Surgeons.

Dr. Carmona has also served for over 28 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction.

In 2002, Dr. Carmona was nominated by the president and unanimously confirmed by the United States Senate to become the 17th Surgeon General of the United States. Dr. Carmona was selected because of his extensive experience in public health, clinical sciences, health care management, preparedness, and his commitment to prevention as an effective means to improve public health and reduce health care costs while improving the quality and quantity of life. As Surgeon General, Dr. Carmona focused on prevention, preparedness, health disparities, health literacy, and global health to include health diplomacy. He also issued many landmark Surgeon General communications during his tenure, including the definitive Surgeon General’s Report about the dangers of second-hand smoke.